RE: Rare Disease Breakthrough Designation8 Oct 2025 09:22
Thanks Phil for the information. Spruce shows that companies can recover from seemingly hopeless positions with the right update.
It seems our sp is starting to slip back again. The volume has dropped, are we heading back to 0.6p? Will we get the phase 1 results and breakthrough drug resubmission this year I wonder. We must be due a shareholder update soon. I know Mike is busy but an update would be appreciated even if just gives us probable dates for things happening.
Thanks